E. Schnitzer et al., LDL-ASSOCIATED PHOSPHOLIPASE-A DOES NOT PROTECT LDL AGAINST LIPID-PEROXIDATION IN-VITRO, Free radical biology & medicine, 24(7-8), 1998, pp. 1294-1303
The irreversible proteinase inhibitor Pefabloc (4-[2-aminoethyl] benze
nesulfonyl fluoride) inactivates LDL-catalyzed hydrolysis of the short
-chain fluorescent phospholipid C-6-NBD-PC -2-(N-4-nitrobenzo-2-oxa-1,
3-diazole)-aminocaproyl phosphatidylcholine). The dose-dependence of t
his inactivation is similar to that obtained previously for the inhibi
tory effect of Pefabloc on the hydrolysis of platelet activating facto
r (PAF) by the LDL-associated PAF acetylhydrolase (PAF-AH), in agreeme
nt with the notion that the hydrolysis of C-6-NBD-PC and PAF is cataly
zed by the same enzyme (LDL-associated phospholipase A; LDL-PLA). This
conclusion is also supported by the finding that hydrolysis of C-6-NB
D-PC by LDL becomes inactivated by LDL oxidation only at late stages o
f the oxidation, similar to the effect of oxidation on the hydrolysis
of PAF by the LDL-associated PAF-AH. Under conditions of complete inac
tivation of this enzyme towards C-6-NBD-PC, the kinetics of lipid pero
xidation, induced either by copper ions or by the free radical generat
or AAPH at varying doses of the prooxidant, was similar to that observ
ed when the PLA was active (i.e., in the absence of Pefabloc). Hence,
LDL-associated PLA (PAF-AH) does not protect LDL lipids from peroxidat
ion. Similar results were obtained with fractionated LDL in albumin-co
ntaining buffer and for non-fractionated serum, in which copper-induce
d peroxidation was also not influenced by inactivation of the enzyme r
esponsible for hydrolysis of C-6-NBD-PC. Phospholipolysis of short cha
in phospholipids by LDL-PLA may still play a protective role against t
he toxic effects of oxidized phospholipids by reducing their internali
zation into cells ( Schmitt et al. 1995). (C) 1998 Elsevier Science In
c.